Jessica Franklin
www.drugepi.org
0000-0002-8941-4116
6 papers found
Refreshing results…
Transparency of high‐dimensional propensity score analyses: Guidance for diagnostics and reporting
Real‐world evidence for assessing pharmaceutical treatments in the context of COVID‐19
Nonrandomized Real‐World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project
Evaluating the Use of Nonrandomized Real‐World Data Analyses for Regulatory Decision Making
Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records
Effects of expanding the look‐back period to all available data in the assessment of covariates
Missing publications? Search for publications with a matching author name.